Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05024760Phase 1Completed
Phase 1 trial of chlorhexidine + cymenol gel and hydrogen peroxide gel in peri-implantitis and peri-implant mucositis (3 arms), sponsored by Madigan Army Medical Center. Primary endpoint: Implant Failure at 4 months. Started Jul 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05024760.